Overview

Properties

Applications

Our Abpromise guarantee covers the use of ab57080 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
  • Application notesWB: Use at a concentration of 1-5 µg/ml.

    This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Involvement in diseaseDefects in ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS) [MIM:606693]; also known as Parkinson disease type 9 (PARK9). KRS is a rare hereditary disease with juvenile onset. In addition to typical signs of Parkinson disease, affected individuals show symptoms of more widespread neurodegeneration, including dementia.
    • Sequence similaritiesBelongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type V subfamily.
    • Cellular localizationMembrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • AT132_HUMAN antibody
      • Atp13a2 antibody
      • ATPase type 13A2 antibody
      • CLN12 antibody
      • FLJ26510 antibody
      • HSA9947 antibody
      • KRPPD antibody
      • PARK9 antibody
      • Probable cation transporting ATPase 13A2 antibody
      • Probable cation-transporting ATPase 13A2 antibody
      • Putative ATPase antibody
      • RP1-37C10.4 antibody
      see all

    Anti-ATP13A2 antibody images

    • Western blot against tagged recombinant protein immunogen using ab57080 ATP13A2 antibody at 1ug/ml. Predicted band size of immunogen is 36 kDa

    References for Anti-ATP13A2 antibody (ab57080)

    ab57080 has not yet been referenced specifically in any publications.

    Product Wall

    Abcam guarantees this product to work in the species/application used in this Abreview.
    Application Western blot
    Sample Human Cell lysate - whole cell (HeLa and Fibroblasts)
    Loading amount 40 µg
    Specification HeLa and Fibroblasts
    Gel Running Conditions Reduced Denaturing (4-12% Bis-Tris)
    Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 22°C
    Username

    Herr Dr. Daniel Meier

    Verified customer

    Submitted Sep 28 2010

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"